ChatGPT: Can You Prepare My Patients for [18F]FDG PET/CT and Explain My Reports?

J Nucl Med. 2023 Dec 1;64(12):1876-1879. doi: 10.2967/jnumed.123.266114.

Abstract

We evaluated whether the artificial intelligence chatbot ChatGPT can adequately answer patient questions related to [18F]FDG PET/CT in common clinical indications before and after scanning. Methods: Thirteen questions regarding [18F]FDG PET/CT were submitted to ChatGPT. ChatGPT was also asked to explain 6 PET/CT reports (lung cancer, Hodgkin lymphoma) and answer 6 follow-up questions (e.g., on tumor stage or recommended treatment). To be rated "useful" or "appropriate," a response had to be adequate by the standards of the nuclear medicine staff. Inconsistency was assessed by regenerating responses. Results: Responses were rated "appropriate" for 92% of 25 tasks and "useful" for 96%. Considerable inconsistencies were found between regenerated responses for 16% of tasks. Responses to 83% of sensitive questions (e.g., staging/treatment options) were rated "empathetic." Conclusion: ChatGPT might adequately substitute for advice given to patients by nuclear medicine staff in the investigated settings. Improving the consistency of ChatGPT would further increase reliability.

Keywords: FDG PET/CT; GPT-4; artificial intelligence; chatbot; patient communication.

MeSH terms

  • Artificial Intelligence
  • Fluorodeoxyglucose F18*
  • Humans
  • Positron Emission Tomography Computed Tomography*
  • Radiopharmaceuticals
  • Reproducibility of Results

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals